Linnea Chap, MD is a highly respected specialist in breast cancer and gynecologic malignancies. She received her B.S. in Chemistry from the University of Illinois and graduated Summa Cum Laude with High Honors. She subsequently received her medical degree from the University of Chicago, Pritzker School of Medicine. Dr. Chap completed residency in internal medicine at Northwestern Memorial Hospital and fellowships in both hematology and oncology at the UCLA Medical Center. After her fellowship, she joined the UCLA faculty where she was promoted to Associate Professor of Medicine and was the co-director of the UCLA/Revlon Multidisciplinary Breast Clinic. Dr. Chap has numerous publications to her credit in highly regarded peer review journals. She has been a leader in the treatment and research of breast and gynecological malignancies and has led several breast and ovarian cancer treatment protocols, including the pioneering use of novel biologic agents such as Herceptin and Avastin. TDM-1 an extraordinary new drug that is like a "smart bomb" which delivers the chemotherapy directly to the cancer cell.
Dr. Linnea I. Chap, MD reveals this new drug and the other medical advancements made for breast cancer.
Health Topics A-Z
Can Anti-perspirants & Deodorants Lead to Breast Cancer?
Guest
: Dr. Linnea I. Chap, MD
From the Show: Staying Well
Summary: Many breast cancers develop in the part of the breast closest to the armpit.
Air Date: 12/10/12
Duration: 10
Host: Melanie Cole, MS
Tagged under